WHO ICTRP trial
Feasibility of ejection fraction measurement with Gallium-68-citrate PET/CT…
NL-OMON34569 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON34569 |
|---|---|
| Public title | Feasibility of ejection fraction measurement with Gallium-68-citrate PET/CT (EF-PET) |
| Scientific title | Feasibility of ejection fraction measurement with Gallium-68-citrate PET/CT (EF-PET) - EF-PET |
| Primary sponsor | Antoni van Leeuwenhoek Ziekenhuis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | Degradation of heart function loss of left ventricular ejection fraction.;10028593;Degradation of heart function;loss of left ventricular ejection fraction. |
| Interventions | ;Ejection fraction;Feasibility;Gallium-citrate;PET/CT |
| Registration date | Jun 1, 2010 |
| Target size | 20 |
| Secondary IDs | NL32006.031.10 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: